Position
Creative Planning in Madrigal Pharmaceuticals, Inc.
Back to the book · All holders of MDGL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$655.9K$582.34 → $523.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 11.1K | $6.49M | — | — | — | 0.0% |
| Q1 2026 | 12K | $6.28M | $523.47 | −$655.9K | $452.3K | 0.0% |